Cargando…
Targeting the ADPKD methylome using nanoparticle-mediated combination therapy
DNA methylation aberrancies are found in autosomal dominant polycystic kidney disease (ADPKD), which suggests the methylome to be a promising therapeutic target. However, the impact of combining DNA methylation inhibitors (DNMTi) and ADPKD drugs in treating ADPKD and on disease-associated methylatio...
Autores principales: | Trinh, Annie, Huang, Yi, Shao, Hanjuan, Ram, Aparna, Morival, Julien, Wang, Jonathan, Chung, Eun Ji, Downing, Timothy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257530/ https://www.ncbi.nlm.nih.gov/pubmed/37305656 http://dx.doi.org/10.1063/5.0151408 |
Ejemplares similares
-
Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022) -
Antenatally Diagnosed ADPKD
por: Aldridge, Melanie, et al.
Publicado: (2018) -
Intrafamilial Variability of ADPKD
por: Lanktree, Matthew B., et al.
Publicado: (2019) -
Simultaneous laparoscopic nephrectomy in ADPKD
por: Baishya, Ramen Kumar, et al.
Publicado: (2010) -
Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)